Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for the prevention of heartworm disease in cats

Special Issue – NexGard^® Combo (esafoxolaner, eprinomectin, praziquantel): A new endectocide spot-on formulation for cats. Invited Editor: Frédéric Beugnet

Open Access

Table 1

Heartworm isolates, study locations and animal details.

Study	Isolate of D. immitis	Study location	Animals
Study	Isolate of D. immitis	Study location	Sex	Bodyweight at treatment (kg)	Age at Infection (months)
Study 1	Berkeley^a	Waverly NY, USA	10 males, 10 females	2.4–5.5	6.1–6.4
Study 2	Georgia II^b	Athens GA, USA	10 males, 10 females	2.0–3.0	3.5–3.7

The Berkeley isolate was obtained in Berkeley County (South Carolina, USA) in April 2014 and maintained in laboratory conditions with three passages since validation in December 2014 at TRS Labs.

The Georgia II isolate was obtained in Vidalia (Georgia, USA) in April 2013 and maintained in Laboratory conditions with one passage since validation in December 2013 at TRS Labs.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.